Skip to main content
. 2022 Feb 22;9:722058. doi: 10.3389/fmed.2022.722058

Table 4.

EPO, hepcidin and IL-6 levels.

mTOR inhibitor based regimen Tacrolimus based regimen p-value
Mean Median SD IQR Mean Median SD IQR
EPO (IU/L) 16.8 11.8 13.1 9.6 8.49 8.5 3.94 5.2 0.028
Hepcidin-25 (nM) 3.62 3.20 2.84 2 3.26 2.6 2.89 4.8 0.76
IL-6 (pg/mL) 11 8.5 6.4 7.65 7.02 5.11 6.65 4.7 0.14